or Try an Advanced Search...

    Technical Analysis for DTIL - Precision BioSciences, Inc.

    Grade Last Price % Change Price Change
    F 11.27 6.62% 0.70
    DTIL closed up 6.62 percent on Wednesday, May 8, 2024, on 62 percent of normal volume.
    Earnings due: May 13
    *** please verify all earnings dates ***
    1 Watcher
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Down Down Up
    Historical DTIL trend table...
    Date Alert Name Type % Chg
    Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 0.00%
    Crossed Above 20 DMA Bullish 0.00%
    Pocket Pivot Bullish Swing Setup 0.00%
    Wide Bands Range Expansion 0.00%
    Gapped Up Strength 0.00%
    Outside Day Range Expansion 6.62%
    Wide Bands Range Expansion 6.62%
    Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 5.72%
    MACD Bullish Signal Line Cross Bullish 5.72%
    NR7 Range Contraction 5.72%
    Older End-of-Day Signals for DTIL ...

       Recent Intraday Alerts

    Alert Time
    Possible Pocket Pivot about 10 hours ago
    60 Minute Opening Range Breakout about 11 hours ago
    Rose Above 20 DMA about 14 hours ago
    20 DMA Support about 14 hours ago
    2x Volume Pace about 15 hours ago
    View Earlier Intraday Alerts

    Get a Trading Sidekick!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Analyze My Stocks!
    Configure default chart indicators
    DTIL Chart by TradingView
    Basic chart:

    Profile

    Precision BioSciences is dedicated to improving life (DTIL) through its proprietary genome editing platform, “ARCUS.” Precision leverages ARCUS in the development of its product candidates, which are designed to treat human diseases and create healthy and sustainable food and agriculture solutions. Precision is actively developing product candidates in three innovative areas: allogeneic CAR T immunotherapy, in vivo gene correction, and food.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Immunotherapy Cancer Treatment Virotherapy Human Diseases Genome Genome Editing

    Is DTIL a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    May 8 Precision BioSciences Announces Common Stock Purchase by Members of Management for $300,000 in a Private Placement
    May 7 Precision BioSciences to Report First Quarter Results on May 13, 2024
    May 7 Precision BioSciences Announces Receipt of FDA Fast Track Designation for ECUR-506, iECURE’s Program for the Treatment of Neonatal Onset Ornithine Transcarbamylase (OTC) Deficiency
    May 1 Precision BioSciences Announces Late-Breaking Poster Presentation at the European Association for Study of the Liver (EASL) Congress 2024
    Apr 17 Intra-Cellular (ITCI) Moves 23.3% Higher: Will This Strength Last?
    Apr 16 Eli Lilly subsidiary, Precision Biosciences end gene therapy collaboration
    Apr 16 Precision BioSciences Announces Return of Programs and Conclusion of Collaboration with Prevail Therapeutics
    Apr 11 Precision BioSciences (DTIL) Now Trades Above Golden Cross: Time to Buy?
    Apr 2 Wall Street Analysts Predict a 407.94% Upside in Precision BioSciences (DTIL): Here's What You Should Know
    Apr 2 Precision BioSciences (DTIL) Soars 13.4%: Is Further Upside Left in the Stock?
    See more DTIL news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 27.015
    52 Week Low 8.25
    Average Volume 146,514
    200-Day Moving Average 12.25
    50-Day Moving Average 12.29
    20-Day Moving Average 10.99
    10-Day Moving Average 10.37
    Average True Range 0.87
    RSI (14) 49.75
    ADX 18.41
    +DI 25.38
    -DI 23.59
    Chandelier Exit (Long, 3 ATRs) 12.04
    Chandelier Exit (Short, 3 ATRs) 11.77
    Upper Bollinger Bands 13.89
    Lower Bollinger Band 8.10
    Percent B (%b) 0.55
    BandWidth 52.65
    MACD Line -0.54
    MACD Signal Line -0.66
    MACD Histogram 0.1249
    Fundamentals Value
    Market Cap 1.37 Billion
    Num Shares 122 Million
    EPS -0.86
    Price-to-Earnings (P/E) Ratio -13.10
    Price-to-Sales 0.94
    Price-to-Book 1.60
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 12.60
    Resistance 3 (R3) 12.48 11.92 12.38
    Resistance 2 (R2) 11.92 11.58 11.98 12.30
    Resistance 1 (R1) 11.60 11.37 11.76 11.71 12.23
    Pivot Point 11.03 11.03 11.12 11.09 11.03
    Support 1 (S1) 10.71 10.70 10.87 10.83 10.31
    Support 2 (S2) 10.15 10.49 10.21 10.24
    Support 3 (S3) 9.82 10.15 10.16
    Support 4 (S4) 9.94